Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer

BACKGROUND: Advanced prostate cancers that are resistant to all current therapies create a need for new therapeutic strategies. One recent innovative approach to cancer therapy is the simultaneous use of multiple FDA-approved drugs to target multiple pathways. A challenge for this approach is caused...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Bao, Powers, Ginny L., Tam, Yu Tong, Schumacher, Nicholas, Malinowski, Rita L., Steinke, Laura, Kwon, Glen, Marker, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370140/
https://www.ncbi.nlm.nih.gov/pubmed/28350865
http://dx.doi.org/10.1371/journal.pone.0174658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370140/
https://www.ncbi.nlm.nih.gov/pubmed/28350865
http://dx.doi.org/10.1371/journal.pone.0174658

Ejemplares similares